A Phase 1b Dose-finding Study of DDFPe in Patients With Acute Ischemic Stroke.
Phase of Trial: Phase I
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Perflenapent (Primary)
- Indications Stroke
- Focus Adverse reactions
- 06 Mar 2017 Status changed from not yet recruiting to recruiting, according to a NuvOx Pharma media release.
- 17 Nov 2016 New trial record